Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Pourzia AL"'
Autor:
Pourzia AL; Harvard Medical School MD-PhD Program, Boston, MA, USA.; Dana Farber Cancer Institute, Division of Hematologic Neoplasia, Boston, MA, USA.; Stanford Internal Medicine Residency, Palo Alto, CA, USA., Olson ML; Dana Farber Cancer Institute, Division of Hematologic Neoplasia, Boston, MA, USA., Bailey SR; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Boston, MA, USA., Boroughs AC; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Boston, MA, USA.; ArsenalBio, South San Francisco, CA, USA., Aryal A; Dana Farber Cancer Institute, Division of Hematologic Neoplasia, Boston, MA, USA., Ryan J; Dana Farber Cancer Institute, Division of Hematologic Neoplasia, Boston, MA, USA., Maus MV; Cellular Immunotherapy Program, Massachusetts General Hospital Cancer Center, Boston, MA, USA. mvmaus@mgh.harvard.edu.; Harvard Medical School, Boston, MA, USA. mvmaus@mgh.harvard.edu., Letai A; Dana Farber Cancer Institute, Division of Hematologic Neoplasia, Boston, MA, USA. anthony_letai@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. anthony_letai@dfci.harvard.edu.
Publikováno v:
Cell death & disease [Cell Death Dis] 2023 Apr 13; Vol. 14 (4), pp. 267. Date of Electronic Publication: 2023 Apr 13.
Autor:
Guerriero JL; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, Massachusetts 02115, USA., Sotayo A; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, Massachusetts 02115, USA., Ponichtera HE; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, Massachusetts 02115, USA., Castrillon JA; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, Massachusetts 02115, USA., Pourzia AL; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, Massachusetts 02115, USA., Schad S; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, Massachusetts 02115, USA., Johnson SF; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, Massachusetts 02115, USA., Carrasco RD; Department of Pathology, Brigham and Women's Hospital, 75 Francis Street, Massachusetts 02115, USA., Lazo S; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, Massachusetts 02115, USA., Bronson RT; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, Massachusetts 02115, USA., Davis SP; GlaxoSmithKline, 200 Technology Square Suite 602, Cambridge, Massachusetts 02139, USA., Lobera M; GlaxoSmithKline, 200 Technology Square Suite 602, Cambridge, Massachusetts 02139, USA., Nolan MA; GlaxoSmithKline, 200 Technology Square Suite 602, Cambridge, Massachusetts 02139, USA., Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, Massachusetts 02115, USA.
Publikováno v:
Nature [Nature] 2017 Mar 16; Vol. 543 (7645), pp. 428-432. Date of Electronic Publication: 2017 Mar 08.
Autor:
Williams KJ; Department of Pathology and Laboratory Medicine, University of California, Los Angeles 90095, USA., Argus JP, Zhu Y, Wilks MQ, Marbois BN, York AG, Kidani Y, Pourzia AL, Akhavan D, Lisiero DN, Komisopoulou E, Henkin AH, Soto H, Chamberlain BT, Vergnes L, Jung ME, Torres JZ, Liau LM, Christofk HR, Prins RM, Mischel PS, Reue K, Graeber TG, Bensinger SJ
Publikováno v:
Cancer research [Cancer Res] 2013 May 01; Vol. 73 (9), pp. 2850-62. Date of Electronic Publication: 2013 Feb 25.
Autor:
Akhavan D; Medical Scientist Training Program, David Geffen School of Medicine, Pourzia AL, Nourian AA, Williams KJ, Nathanson D, Babic I, Villa GR, Tanaka K, Nael A, Yang H, Dang J, Vinters HV, Yong WH, Flagg M, Tamanoi F, Sasayama T, James CD, Kornblum HI, Cloughesy TF, Cavenee WK, Bensinger SJ, Mischel PS
Publikováno v:
Cancer discovery [Cancer Discov] 2013 May; Vol. 3 (5), pp. 534-47. Date of Electronic Publication: 2013 Mar 26.